Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712484
What this trial is testing
A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC
Who this might be right for
CoccidioidomycosisDisseminated Fungal InfectionCoccidioides Infection+5 more
F2G Ltd 50